348 related articles for article (PubMed ID: 22152414)
21. [Association between membranous glomerulonephritis and Crohn's disease].
Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
[TBL] [Abstract][Full Text] [Related]
22. [Angioedema in Crohn's disease possibly due to mesalazine].
Nguyen-Khac E; Le Baron F; Thevenot T; Tiry-Lescut C; Tiry F
Gastroenterol Clin Biol; 2002 May; 26(5):535-6. PubMed ID: 12122371
[No Abstract] [Full Text] [Related]
23. Mesalazine-induced lupus.
Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
[TBL] [Abstract][Full Text] [Related]
24. [Hypersensitivity to 5-aminosalicylic acid. Value of desensitization by oral route].
Lachaux A; Le Gall C; Loras-Duclaux I; Aboufadel A; Hermier M
Arch Pediatr; 1997 Feb; 4(2):144-6. PubMed ID: 9097825
[TBL] [Abstract][Full Text] [Related]
25. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
[TBL] [Abstract][Full Text] [Related]
26. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
27. [Severe chronic interstitial nephritis associated with Crohn's disease, but not with mesalazine?].
Baumer P; Brocard JF; Kohn W; Bedossa P; Charpentier B
Gastroenterol Clin Biol; 1999 Dec; 23(12):1400-2. PubMed ID: 10642629
[No Abstract] [Full Text] [Related]
28. Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis.
Tsuboi R; Matsumoto S; Miyatani H; Mashima H
Intern Med; 2019 Mar; 58(5):649-654. PubMed ID: 30333413
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary complications in patients with inflammatory bowel disease.
Kuzela L; Vavrecka A; Prikazska M; Drugda B; Hronec J; Senkova A; Drugdova M; Oltman M; Novotna T; Brezina M; Kratky A; Kristufek P
Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329
[TBL] [Abstract][Full Text] [Related]
30. [Chronic interstitial nephritis and mesalazine: 3 new cases?].
Brouillard M; Gheerbrant JD; Gheysens Y; Fleury D; Devred M; Hazzan M; Colombel JF
Gastroenterol Clin Biol; 1998; 22(8-9):724-6. PubMed ID: 9823562
[TBL] [Abstract][Full Text] [Related]
31. Sulfasalazine, 5-ASA and acute pancreatitis in crohn's disease.
Debongnie JC; Dekoninck X
J Clin Gastroenterol; 1994 Dec; 19(4):348-9. PubMed ID: 7876525
[No Abstract] [Full Text] [Related]
32. [A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis].
Kim KH; Kim TN; Jang BI
Korean J Gastroenterol; 2007 Dec; 50(6):379-83. PubMed ID: 18159175
[TBL] [Abstract][Full Text] [Related]
33. Review article: chronic active disease and maintaining remission in Crohn's disease.
Kamm MA
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():102-5. PubMed ID: 15352904
[TBL] [Abstract][Full Text] [Related]
34. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
35. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
Moum B
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
[TBL] [Abstract][Full Text] [Related]
36. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
Maier K; Fischer C; Klotz U; Heinkel K
Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
[TBL] [Abstract][Full Text] [Related]
37. [Acute pancreatitis due to 5-aminosalicylic acid].
Romero Castro R; Jiménez Sáenz M; Pellicer Bautista FJ; Domínguez Palomo S; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 1991 Mar; 79(3):219-21. PubMed ID: 2043409
[TBL] [Abstract][Full Text] [Related]
38. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
Nakshabendi IM; Duncan A; Russell RI
Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
[TBL] [Abstract][Full Text] [Related]
39. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis.
Deltenre P; Berson A; Marcellin P; Degott C; Biour M; Pessayre D
Gut; 1999 Jun; 44(6):886-8. PubMed ID: 10323894
[TBL] [Abstract][Full Text] [Related]
40. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]